ATC code B01

ATC codes

B03 Antianemic preparations

B05 Blood substitutes and perfusion solutions

B06 Other hematological agents

ATC code B01 Antithrombotic agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup B01 is part of the anatomical group B Blood and blood forming organs.^[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QB01.^[2]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

B01A Antithrombotic agents

B01AA Vitamin K antagonists

B01AA01 Dicoumarol

B01AA02 Phenindione

B01AA03 Warfarin

B01AA04 Phenprocoumon

B01AA07 Acenocoumarol

B01AA08 Ethyl biscoumacetate

B01AA09 Clorindione

B01AA10 Diphenadione

B01AA11 Tioclomarol

B01AA12 Fluindione

B01AB Heparin group

B01AB01 Heparin

B01AB02 Antithrombin III

B01AB04 Dalteparin

B01AB05 Enoxaparin

B01AB06 Nadroparin

B01AB07 Parnaparin

B01AB08 Reviparin

B01AB09 Danaparoid

B01AB10 Tinzaparin

B01AB11 Sulodexide

B01AB12 Bemiparin

B01AB51 Heparin, combinations

B01AC Platelet aggregation inhibitors excluding heparin

B01AC01 Ditazole

B01AC02 Cloricromen

B01AC03 Picotamide

B01AC04 Clopidogrel

B01AC05 Ticlopidine

B01AC06 Acetylsalicylic acid

B01AC07 Dipyridamole

B01AC08 Carbasalate calcium

B01AC09 Epoprostenol

B01AC10 Indobufen

B01AC11 Iloprost

B01AC13 Abciximab

B01AC15 Aloxiprin

B01AC16 Eptifibatide

B01AC17 Tirofiban

B01AC18 Triflusal

B01AC19 Beraprost

B01AC21 Treprostinil

B01AC22 Prasugrel

B01AC23 Cilostazol

B01AC24 Ticagrelor

B01AC25 Cangrelor

B01AC26 Vorapaxar

B01AC27 Selexipag

B01AC30 Combinations

B01AC56 Acetylsalicylic acid, combinations with proton pump inhibitors

B01AD Enzymes

B01AD01 Streptokinase

B01AD02 Alteplase

B01AD03 Anistreplase

B01AD04 Urokinase

B01AD05 Fibrinolysin

B01AD06 Brinase

B01AD07 Reteplase

B01AD08 Saruplase

B01AD09 Ancrod

B01AD10 Drotrecogin alfa (activated)

B01AD11 Tenecteplase

B01AD12 Protein C

References

↑ "ATC/DDD Index 2016: code B01". WHO Collaborating Centre for Drug Statistics Methodology.
↑ "ATCvet Index 2016: code QB01". WHO Collaborating Centre for Drug Statistics Methodology.

Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01)

Antiplatelet drugs

Glycoprotein IIb/IIIa inhibitors	Abciximab Eptifibatide Orbofiban Roxifiban Sibrafiban^§ Tirofiban

ADP receptor/P2Y₁₂ inhibitors	Thienopyridines Clopidogrel Prasugrel Ticlopidine Nucleotide/nucleoside analogs Cangrelor Elinogrel Ticagrelor

Prostaglandin analogue (PGI2)	Beraprost Iloprost Prostacyclin Treprostinil

COX inhibitors	Acetylsalicylic acid/Aspirin^# Aloxiprin Carbasalate calcium Indobufen Triflusal

Thromboxane inhibitors	Thromboxane synthase inhibitors Dipyridamole (+ aspirin) Picotamide Terbogrel Receptor antagonists Terbogrel Terutroban^§

Phosphodiesterase inhibitors	Cilostazol Dipyridamole Triflusal

Other	Cloricromen Ditazole Vorapaxar

Anticoagulants

Vitamin K antagonists
(inhibit II, VII, IX, X)

Factor Xa inhibitors
(with some II inhibition)

Heparin group/ glycosaminoglycans/ (bind antithrombin)	Low molecular weight heparin Bemiparin Certoparin Dalteparin Enoxaparin Nadroparin Parnaparin Reviparin Tinzaparin^‡ Oligosaccharides Fondaparinux Idraparinux^§ Heparinoids Danaparoid Dermatan sulfate Sulodexide

Direct Xa inhibitors ("xabans")	Apixaban Betrixaban^† Darexaban^§ Edoxaban Otamixaban^§ Rivaroxaban

Direct thrombin (IIa) inhibitors

Other

Thrombolytic drugs/
fibrinolytics

Non-medicinal

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

This article is issued from Wikipedia - version of the 1/4/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.